NumerixS Investment Technologies’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-214
Closed -$19K 358
2020
Q2
$19K Buy
214
+114
+114% +$11.5K 0.01% 955
2020
Q1
$10K Sell
100
-200
-67% -$21.7K 0.01% 892
2019
Q4
$34K Sell
300
-700
-70% -$84.7K 0.01% 880
2019
Q3
$126K Buy
+1,000
New +$127K 0.03% 503
2019
Q2
Sell
-600
Closed -$52K 1190
2019
Q1
$52K Buy
600
+500
+500% +$45.5K 0.01% 984
2018
Q4
$10K Sell
100
-258
-72% -$27.1K ﹤0.01% 996
2018
Q3
$41K Buy
+358
New +$37.1K 0.01% 1008
2018
Q1
Sell
-400
Closed -$23K 1137
2017
Q4
$23K Sell
400
-1,500
-79% -$79K 0.01% 981
2017
Q3
$85K Sell
1,900
-2,500
-57% -$104K 0.02% 801
2017
Q2
$174K Buy
+4,400
New +$181K 0.03% 684
2017
Q1
Sell
-400
Closed -$16K 1234
2016
Q4
$16K Buy
+400
New +$15.1K ﹤0.01% 1046

Other funds holding HAE

NumerixS Investment Technologies's HAE Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Haemonetics (HAE) in Q3 2020, closing a stake of 214 shares — an estimated $19K sold.

NumerixS Investment Technologies first reported a position in HAE in Q4 2016 and held it in 11 quarters. The position peaked at $174K in Q2 2017. 268 funds tracked by Wall St. Rank hold HAE as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Haemonetics position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 214 Haemonetics shares in Q3 2020, an estimated $19K.
  • NumerixS Investment Technologies first reported a position in Haemonetics in Q4 2016 and held it in 11 quarters.
  • NumerixS Investment Technologies's Haemonetics position peaked at $174K in Q2 2017.
  • 268 funds tracked by Wall St. Rank held Haemonetics as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.